Provided by Tiger Fintech (Singapore) Pte. Ltd.

InspireMD

2.52
+0.12705.31%
Pre-market: 2.520.0200+0.80%08:55 EDT
Volume:52.92K
Turnover:130.27K
Market Cap:77.11M
PE:-3.19
High:2.54
Open:2.42
Low:2.39
Close:2.39
Loading ...

InspireMD to Announce Second Quarter 2025 Financial Results

GlobeNewswire
·
2 hours ago

Lake Street Keeps Their Buy Rating on InspireMD (NSPR)

TIPRANKS
·
09 Jul

InspireMD Announces U.S. Commercial Launch of Cguard® Prime Carotid Stent System for the Prevention of Stroke

THOMSON REUTERS
·
09 Jul

InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke

GlobeNewswire
·
09 Jul

InspireMD Inc. Files Initial Statement of Beneficial Ownership for CFO Michael A. Lawless

Reuters
·
27 Jun

Lake Street Remains a Buy on InspireMD (NSPR)

TIPRANKS
·
25 Jun

InspireMD Gains FDA Approval for CGuard Stent System

TIPRANKS
·
25 Jun

InspireMD Stock Surges on FDA Approval for CGuard Stent

Dow Jones
·
25 Jun

BRIEF-InspireMD Says FDA Approval Triggers Second Warrant Tranche In $113.6 Million Financing

Reuters
·
25 Jun

InspireMD Announces FDA Approval for Cguard® Prime Carotid Stent System for the Prevention of Stroke

THOMSON REUTERS
·
25 Jun

InspireMD Inc - FDA Approval Triggers Second Warrant Tranche in $113.6 Mln Financing

THOMSON REUTERS
·
25 Jun

InspireMD Secures CE Mark Approval for CGuard® Prime EPS, Paving Way for European Launch

Reuters
·
13 Jun

InspireMD Holds Annual Stockholders Meeting and Elections

TIPRANKS
·
04 Jun

InspireMD Inc. Appoints Michael Lawless as New Chief Financial Officer Amidst Strategic Growth Phase

Reuters
·
04 Jun

InspireMD Inc. Conducted Annual Stockholders Meeting

Reuters
·
04 Jun

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

THOMSON REUTERS
·
04 Jun

InspireMD Is Maintained at Overweight by Piper Sandler

Dow Jones
·
13 May

InspireMD (NSPR) Gets a Buy from Lake Street

TIPRANKS
·
12 May

InspireMD Inc. Reports Q1 2025 Financial Results

TIPRANKS
·
10 May

InspireMD Inc’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
10 May